Otsuka and Click Therapeutics Initiate First-of-its-Kind Fully Remote Clinical Trial Using...

"Otsuka and Click Therapeutics Initiate First-of-its-Kind Fully Remote Clinical Trial Using Digital Therapeutics as Adjunctive Therapy in Adults With Major Depressive Disorder

Primary objective of the Mirai study is to evaluate the effectiveness of digital therapeutics to reduce depressive symptoms in adults diagnosed with major depressive disorder (MDD) who are on antidepressant monotherapy

Trial will run fully remotely utilizing the Verily Project Baseline platform, a first-of-its-kind trial design for MDD

Otsuka is committed to exploring digital therapeutics in patients with serious mental illnesses like MDD, which affects more than 17 million adults in the US..."

022421 Otsuka and Click Therapeutics Ini

.

Download • 117KB